Business NewsPR NewsWire • Interim Report Q3, 2020

Interim Report Q3, 2020

Interim Report Q3, 2020

STOCKHOLM, Nov. 12, 2020 /PRNewswire/ -- "On August 13th, we announced a €19.8m acquisition of a majority stake of 62.7% in Genkyotex, a publicly listed life science company in France. We are very excited about this acquisition, which complements our existing and long-standing focus on...

View More : https://www.prnewswire.com:443/news-releases/interim-report-q3-2020-301171586.html
Releted News by prnewswire
AANP Honors the Nation's Veterans, Proud to Provide Care During COVID-19
Obsidian Insurance Holdings, Inc.'s New E&S Subsidiary Secures A- Rating From AM Best
2020 Indian Cards and Payments Market Report, Featuring Key Vendors HDFC Bank, ICICI Bank, RuPay, Jio Money and More
Interim Report Q3, 2020
Jubilant Therapeutics and OneThree Biotech Collaborate to Advance Precision Oncology
Electric Toothbrush Market Revenue Worth $4.8 Billion by 2030: P&S Intelligence